Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Journal of the American College of Cardiology
|
January 28, 2026
Association Between Age and PCI Effectiveness in Stable CAD: Secondary Analysis of ORBITA-2
Florentina A Simader, Christopher A Rajkumar, Michael J Foley, et al.
Circulation
|
October 27, 2024
Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Coronary Artery Disease
Michael J Foley, Christopher A Rajkumar, Fiyyaz Ahmed-Jushuf, et al.
European Heart Journal. Digital Health
|
August 4, 2023
Development of artificial intelligence tools for invasive Doppler-based coronary microvascular assessment
Henry Seligman, Sapna B Patel, Anissa Alloula, et al.
Journal of the American College of Cardiology
|
May 16, 2024
N-of-1 Trial of Angina Verification Before Percutaneous Coronary Intervention
Christopher A Rajkumar, Michael J Foley, Fiyyaz Ahmed-Jushuf, et al.
Circulation
|
May 8, 2026
Determining the Physiological Threshold for Angina (ORBITA-FIRE): A Double-Blind, Randomized, Placebo-Controlled Study
Fiyyaz Ahmed-Jushuf, Michael J Foley, Shayna Chotai, et al.
Circulation
|
October 27, 2025
The Role of the Collateral Circulation in Stable Angina: An Invasive Placebo-Controlled Study
Christopher A Rajkumar, Michael J Foley, Fiyyaz Ahmed-Jushuf, et al.
Circulation. Cardiovascular Interventions
|
August 3, 2021
Placebo-Controlled Efficacy of Percutaneous Coronary Intervention for Focal and Diffuse Patterns of Stable Coronary Artery Disease
Christopher A Rajkumar, Matthew Shun-Shin, Henry Seligman, et al.
Journal of the American College of Cardiology
|
May 17, 2024
Symptoms as a Predictor of the Placebo-Controlled Efficacy of PCI in Stable Coronary Artery Disease
Florentina A Simader, Christopher A Rajkumar, Michael J Foley, et al.
Lancet (London, England)
|
April 11, 2024
Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trial
Michael J Foley, Christopher A Rajkumar, Fiyyaz Ahmed-Jushuf, et al.
Journal of the American College of Cardiology
|
May 7, 2025
Ischemia on Dobutamine Stress Echocardiography Predicts Efficacy of PCI: Results From the ORBITA-2 Trial
Fiyyaz Ahmed-Jushuf, Michael J Foley, Christopher A Rajkumar, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Journal of the American College of Cardiology
|
January 28, 2026
Association Between Age and PCI Effectiveness in Stable CAD: Secondary Analysis of ORBITA-2
Florentina A Simader, Christopher A Rajkumar, Michael J Foley, et al.
Circulation
|
October 27, 2024
Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Coronary Artery Disease
Michael J Foley, Christopher A Rajkumar, Fiyyaz Ahmed-Jushuf, et al.
European Heart Journal. Digital Health
|
August 4, 2023
Development of artificial intelligence tools for invasive Doppler-based coronary microvascular assessment
Henry Seligman, Sapna B Patel, Anissa Alloula, et al.
Journal of the American College of Cardiology
|
May 16, 2024
N-of-1 Trial of Angina Verification Before Percutaneous Coronary Intervention
Christopher A Rajkumar, Michael J Foley, Fiyyaz Ahmed-Jushuf, et al.
Circulation
|
May 8, 2026
Determining the Physiological Threshold for Angina (ORBITA-FIRE): A Double-Blind, Randomized, Placebo-Controlled Study
Fiyyaz Ahmed-Jushuf, Michael J Foley, Shayna Chotai, et al.
Circulation
|
October 27, 2025
The Role of the Collateral Circulation in Stable Angina: An Invasive Placebo-Controlled Study
Christopher A Rajkumar, Michael J Foley, Fiyyaz Ahmed-Jushuf, et al.
Circulation. Cardiovascular Interventions
|
August 3, 2021
Placebo-Controlled Efficacy of Percutaneous Coronary Intervention for Focal and Diffuse Patterns of Stable Coronary Artery Disease
Christopher A Rajkumar, Matthew Shun-Shin, Henry Seligman, et al.
Journal of the American College of Cardiology
|
May 17, 2024
Symptoms as a Predictor of the Placebo-Controlled Efficacy of PCI in Stable Coronary Artery Disease
Florentina A Simader, Christopher A Rajkumar, Michael J Foley, et al.
Lancet (London, England)
|
April 11, 2024
Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trial
Michael J Foley, Christopher A Rajkumar, Fiyyaz Ahmed-Jushuf, et al.
Journal of the American College of Cardiology
|
May 7, 2025
Ischemia on Dobutamine Stress Echocardiography Predicts Efficacy of PCI: Results From the ORBITA-2 Trial
Fiyyaz Ahmed-Jushuf, Michael J Foley, Christopher A Rajkumar, et al.
Page
of 4